108,575 Shares in Stericycle, Inc. (NASDAQ:SRCL) Acquired by Mesirow Institutional Investment Management Inc.

Mesirow Institutional Investment Management Inc. bought a new stake in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 108,575 shares of the business services provider's stock, valued at approximately $5,381,000. Mesirow Institutional Investment Management Inc. owned about 0.12% of Stericycle at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of SRCL. Principal Securities Inc. purchased a new position in Stericycle in the fourth quarter worth $41,000. Ramirez Asset Management Inc. bought a new position in shares of Stericycle during the 3rd quarter valued at about $45,000. Essex Investment Management Co. LLC lifted its position in Stericycle by 16.8% in the 3rd quarter. Essex Investment Management Co. LLC now owns 2,691 shares of the business services provider's stock worth $120,000 after buying an additional 387 shares during the last quarter. Blue Trust Inc. boosted its stake in Stericycle by 15.4% in the fourth quarter. Blue Trust Inc. now owns 3,125 shares of the business services provider's stock worth $155,000 after buying an additional 416 shares in the last quarter. Finally, Pathstone Family Office LLC purchased a new stake in Stericycle in the third quarter worth approximately $230,000. Hedge funds and other institutional investors own 98.82% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on SRCL shares. StockNews.com cut shares of Stericycle from a "buy" rating to a "hold" rating in a research note on Tuesday, April 2nd. Wells Fargo & Company increased their target price on Stericycle from $40.00 to $48.00 and gave the company an "underweight" rating in a report on Friday, March 1st. Truist Financial lowered their price objective on Stericycle from $57.00 to $50.00 and set a "hold" rating for the company in a research report on Monday, April 29th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $69.00 target price on shares of Stericycle in a research note on Thursday, March 7th. Finally, Robert W. Baird dropped their price target on shares of Stericycle from $62.00 to $55.00 and set a "neutral" rating for the company in a research report on Friday, April 26th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $59.40.

Stericycle Trading Up 0.1 %

SRCL stock traded up $0.03 on Friday, reaching $46.94. The company's stock had a trading volume of 288,265 shares, compared to its average volume of 522,694. The firm has a market cap of $4.36 billion, a PE ratio of -213.36, a PEG ratio of 2.53 and a beta of 1.12. The business has a fifty day simple moving average of $50.31 and a two-hundred day simple moving average of $48.49. Stericycle, Inc. has a 12-month low of $37.78 and a 12-month high of $57.06. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11.

Stericycle (NASDAQ:SRCL - Get Free Report) last posted its earnings results on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, topping the consensus estimate of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The firm had revenue of $664.90 million during the quarter, compared to analysts' expectations of $676.42 million. During the same period last year, the company posted $0.49 EPS. The company's quarterly revenue was down 2.8% compared to the same quarter last year. As a group, research analysts forecast that Stericycle, Inc. will post 2.32 EPS for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.